159 related articles for article (PubMed ID: 16201502)
1. [Inhibition of cellular adhesion and invasion in gliomas].
Sasaki H; Yoshida K
Nihon Rinsho; 2005 Sep; 63 Suppl 9():68-73. PubMed ID: 16201502
[No Abstract] [Full Text] [Related]
2. ECM-mediated glioma cell invasion.
Goldbrunner RH; Bernstein JJ; Tonn JC
Microsc Res Tech; 1998 Nov; 43(3):250-7. PubMed ID: 9840803
[TBL] [Abstract][Full Text] [Related]
3. [Role of extracellular matrix degradation enzyme for glioma invasion].
Nakada M
Nihon Rinsho; 2005 Sep; 63 Suppl 9():55-60. PubMed ID: 16201500
[No Abstract] [Full Text] [Related]
4. Adhesion molecules and the extracellular matrix as drug targets for glioma.
Shimizu T; Kurozumi K; Ishida J; Ichikawa T; Date I
Brain Tumor Pathol; 2016 Apr; 33(2):97-106. PubMed ID: 26992378
[TBL] [Abstract][Full Text] [Related]
5. [Molecular mechanisms of brain tumor invasion].
Saya H
Nihon Rinsho; 2005 Sep; 63 Suppl 9():61-7. PubMed ID: 16201501
[No Abstract] [Full Text] [Related]
6. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.
VanMeter TE; Rooprai HK; Kibble MM; Fillmore HL; Broaddus WC; Pilkington GJ
J Neurooncol; 2001 Jun; 53(2):213-35. PubMed ID: 11716072
[TBL] [Abstract][Full Text] [Related]
7. AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix.
Piao Y; Lu L; de Groot J
Neuro Oncol; 2009 Jun; 11(3):260-73. PubMed ID: 18957620
[TBL] [Abstract][Full Text] [Related]
8. Integrins: molecular determinants of glioma invasion.
D'Abaco GM; Kaye AH
J Clin Neurosci; 2007 Nov; 14(11):1041-8. PubMed ID: 17954373
[TBL] [Abstract][Full Text] [Related]
9. [Matrix metalloproteinase inhibitors for therapy of cancer].
Sone S; Shiraga M
Nihon Rinsho; 2001 Apr; 59 Suppl 4():431-7. PubMed ID: 11424420
[No Abstract] [Full Text] [Related]
10. [Role of neural cell adhesion molecule L1 in glioma invasion].
Izumoto S; Yoshimine T
Nihon Rinsho; 2005 Sep; 63 Suppl 9():74-8. PubMed ID: 16201503
[No Abstract] [Full Text] [Related]
11. [Research on the antimetastatic agents].
Takeshima H
Nihon Rinsho; 2005 Sep; 63 Suppl 9():79-85. PubMed ID: 16201504
[No Abstract] [Full Text] [Related]
12. Suberoylanilide hydroxamic acid limits migration and invasion of glioma cells in two and three dimensional culture.
An Z; Gluck CB; Choy ML; Kaufman LJ
Cancer Lett; 2010 Jun; 292(2):215-27. PubMed ID: 20060208
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of glioma invasiveness: the role of proteases.
Rao JS
Nat Rev Cancer; 2003 Jul; 3(7):489-501. PubMed ID: 12835669
[TBL] [Abstract][Full Text] [Related]
14. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg.
Annabi B; Bouzeghrane M; Moumdjian R; Moghrabi A; Béliveau R
J Neurochem; 2005 Aug; 94(4):906-16. PubMed ID: 15992376
[TBL] [Abstract][Full Text] [Related]
15. Interstitial guidance of cancer invasion.
Gritsenko PG; Ilina O; Friedl P
J Pathol; 2012 Jan; 226(2):185-99. PubMed ID: 22006671
[TBL] [Abstract][Full Text] [Related]
16. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 3: brain tumor invasiveness.
Newton HB
Expert Rev Anticancer Ther; 2004 Oct; 4(5):803-21. PubMed ID: 15485315
[TBL] [Abstract][Full Text] [Related]
17. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma inhibits proliferation and adhesion of T98G human malignant glioma cells in vitro.
Knüpfer MM; Poppenborg H; Van Gool S; Domula M; Wolff JE
Klin Padiatr; 1997; 209(4):271-4. PubMed ID: 9293461
[TBL] [Abstract][Full Text] [Related]
19. CD44 mediates human glioma cell adhesion and invasion in vitro.
Merzak A; Koocheckpour S; Pilkington GJ
Cancer Res; 1994 Aug; 54(15):3988-92. PubMed ID: 7518347
[TBL] [Abstract][Full Text] [Related]
20. Cilengitide treatment for malignant glioma: current status and future direction.
Kurozumi K; Ichikawa T; Onishi M; Fujii K; Date I
Neurol Med Chir (Tokyo); 2012; 52(8):539-47. PubMed ID: 22976135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
